GW572016 In Patients With ErbB2 Over - Expressing Advanced Or Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Neoplasms, Breast
Interventions: DRUG: lapatinib
Sponsor: GlaxoSmithKline